Actively Recruiting

Phase 4
Age: 2Years +
All Genders
Healthy Volunteers
NCT05745987

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

Led by McMaster University · Updated on 2025-07-06

3000

Participants Needed

10

Research Sites

115 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A cluster randomized controlled trial to determine if smallpox vaccine reduces secondary cases and symptom severity in persons exposed to mpox.

CONDITIONS

Official Title

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

Who Can Participate

Age: 2Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be a household member of a person with laboratory confirmed monkeypox
  • Be aged 2 years or older
  • Be within 14 days of illness onset in the monkeypox index case
Not Eligible

You will not qualify if you...

  • Be pregnant
  • Be breastfeeding
  • Have had a past serious allergic reaction to components of the study vaccines
  • Have previously received smallpox vaccination
  • Be currently using or planning to use another investigational drug during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Catholic University of Bukavu

Kinshasa, Bukavu, Democratic Republic of the Congo

Actively Recruiting

2

Federal Medical Center

Abuja, Nigeria

Not Yet Recruiting

3

University of Abuja Teaching Hospital

Abuja, Nigeria

Not Yet Recruiting

4

University of Ibadan

Ibadan, Nigeria

Not Yet Recruiting

5

Irrua Specialist Teaching Hospital

Irrua, Nigeria

Not Yet Recruiting

6

Aminu Kano Teaching Hospital

Kano, Nigeria

Not Yet Recruiting

7

Lagos University Teaching Hospital

Lagos, Nigeria

Not Yet Recruiting

8

Niger Delta Teaching Hospital

Okolobiri, Nigeria

Not Yet Recruiting

9

University of Port Harcourt Teaching Hospital

Port Harcourt, Nigeria

Not Yet Recruiting

10

Makerere University Lung Institute

Kampala, Uganda

Not Yet Recruiting

Loading map...

Research Team

M

Mark Loeb, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here